DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/23ec8bae/pneumonia_pipeli) has announced the addition of Global Markets Direct's new report "Pneumonia - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Pneumonia - Pipeline Review, H1 2012', provides an overview of the Pneumonia therapeutic pipeline. This report provides information on the therapeutic development for Pneumonia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pneumonia. 'Pneumonia - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Key Topics Covered:
- Introduction
- Global Markets Direct Report Coverage
- Pneumonia Overview
- Therapeutics Development
- An Overview of Pipeline Products for Pneumonia
- Pneumonia Therapeutics under Development by Companies
- Pneumonia Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Pneumonia Therapeutics - Products under Development by Companies
- Pneumonia Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Pneumonia Therapeutics Development
- APEPTICO Forschung und Entwicklung GmbH
- Pneumonia - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Pneumonia Therapeutics - Drug Profile Updates
- Pneumonia Therapeutics - Discontinued Products
- Pneumonia Therapeutics - Dormant Products
- Pneumonia - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
Companies Mentioned:
- Johnson & Johnson
- Sequella, Inc.
- AstraZeneca PLC
- GlaxoSmithKline plc
- Nektar Therapeutics
- Takeda Pharmaceutical Company Limited
- Nanotherapeutics, Inc.
- Rib-X Pharmaceuticals, Inc.
- Optimer Pharmaceuticals, Inc.
- Bayer AG
- Intercell AG
- Basilea Pharmaceutica Ltd.
- Oragenics, Inc.
- Pacgen Biopharmaceuticals Corporation
- Advanced Life Sciences Holdings, Inc.
- Lipoxen PLC
- Dongwha Pharm Co., Ltd.
- Synairgen plc
- Eurocine Vaccines AB
- Mucosis B.V.
- Aridis Pharmaceuticals LLC
- Kenta Biotech Ltd.
- aRigen Pharmaceuticals, Inc.
- Nabriva Therapeutics AG
- Enanta Pharmaceuticals, Inc.
- KaloBios Pharmaceuticals, Inc.
- Trius Therapeutics, Inc.
- Tetraphase Pharmaceuticals Inc.
- TaiGen Biotechnology Co., Ltd.
- Endacea, Inc.
For more information visit http://www.researchandmarkets.com/research/23ec8bae/pneumonia_pipeli
Source: Global Markets Direct